MedPath
FDA Approval

Fluvoxamine Maleate

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
June 14, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Fluvoxamine(100 mg in 1 1)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Preferred Pharmaceuticals Inc.

791119022

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Preferred Pharmaceuticals Inc..

Preferred Pharmaceuticals Inc.

Preferred Pharmaceuticals Inc.

791119022

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Fluvoxamine Maleate

Product Details

NDC Product Code
68788-8175
Application Number
ANDA075902
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
June 14, 2023
Code: 5LGN83G74VClass: ACTIBQuantity: 100 mg in 1 1
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%)Inactive
Code: 8136Y38GY5Class: IACT
POLYETHYLENE GLYCOL 8000Inactive
Code: Q662QK8M3BClass: IACT
MANNITOLInactive
Code: 3OWL53L36AClass: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JPClass: IACT
FERRIC OXIDE YELLOWInactive
Code: EX438O2MRTClass: IACT
FERRIC OXIDE REDInactive
Code: 1K09F3G675Class: IACT
FERROSOFERRIC OXIDEInactive
Code: XM0M87F357Class: IACT
© Copyright 2025. All Rights Reserved by MedPath